Citation: Jc. Hartman, A LINEAR-PROGRAMMING FORMULATION WITH INTEGER SOLUTIONS FOR SOLVING AN EQUIPMENT REPLACEMENT-PROBLEM WITH MULTIPLE ASSETS - THE CONCAVE DEMAND CASE, International Journal of Systems Science, 29(11), 1998, pp. 1225-1234
Citation: Tm. Wall et al., PRESERVATION OF CORONARY-ARTERY ENDOTHELIAL-MEDIATED VASODILATION BY CHRONIC ORAL-ADMINISTRATION OF PROBUCOL IN A UNIQUE IN-VIVO RABBIT MODEL OF CHOLESTEROL-INDUCED ENDOTHELIAL DYSFUNCTION, Circulation, 96(8), 1997, pp. 3397-3397
Citation: Tm. Wall et al., RAMIPRILAT ATTENUATES HYPOXIA REOXYGENATION INJURY TO CARDIAC MYOCYTES VIA A BRADYKININ-DEPENDENT MECHANISM/, European journal of pharmacology, 306(1-3), 1996, pp. 165-174
Citation: Tg. Hullinger et al., THE EFFECT OF P-SELECTIN BLOCKADE ON NEOINTIMAL LESION DEVELOPMENT INA PRIMATE CAROTID INJURY MODEL, The FASEB journal, 9(4), 1995, pp. 845-845
Citation: Tm. Wall et al., THE TEMPORAL RELATIONSHIP BETWEEN BRADYKININ AND K-ATP CHANNELS IN THE MECHANISM OF CARDIOPROTECTIVE ISCHEMIC PRECONDITIONING, Circulation, 92(8), 1995, pp. 1203-1203
Authors:
DEGRAAF GL
HARTMAN JC
STEELE AN
ANDERSON DC
MARTIN JP
HERBERG JT
KIRSCHNER RJ
TREAT JC
BEIDERMAN B
PHILLIPS ML
SHEBUSKI RJ
Citation: Gl. Degraaf et al., ANTAGONISM OF P-SELECTIN WITH CY1748 ACCELERATES THROMBOLYSIS IN A PRIMATE MODEL OF ARTERIAL THROMBOSIS, Circulation, 92(8), 1995, pp. 2327-2327
Authors:
HARTMAN JC
ANDERSON DC
WILTSE AL
LANE CL
ROSENBLOOM CL
MANNING AM
HUMPHREY WR
WALL TM
SHEBUSKI RJ
Citation: Jc. Hartman et al., PROTECTION OF ISCHEMIC REPERFUSED CANINE MYOCARDIUM BY CL18/6, A MONOCLONAL-ANTIBODY TO ADHESION MOLECULE ICAM-1/, Cardiovascular Research, 30(1), 1995, pp. 47-54
Citation: Jc. Hartman, THE ROLE OF BRADYKININ AND NITRIC-OXIDE IN THE CARDIOPROTECTIVE ACTION OF ACE-INHIBITORS, The Annals of thoracic surgery, 60(3), 1995, pp. 789-792
Authors:
HARTMAN JC
OLSZANSKI DA
HULLINGER TG
BRUNDEN MN
Citation: Jc. Hartman et al., IN-VIVO VALIDATION OF A TRANSIT-TIME ULTRASONIC VOLUME FLOW METER, Journal of pharmacological and toxicological methods, 31(3), 1994, pp. 153-160
Citation: Jc. Hartman et al., INHIBITION OF NITRIC-OXIDE SYNTHASE PREVENTS MYOCARDIAL PROTECTION BYRAMIPRILAT, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1071-1076
Citation: Tm. Wall et al., ROLE OF BRADYKININ IN MYOCARDIAL PRECONDITIONING, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 681-689
Citation: Da. Linseman et al., THE TROLOX ANALOG, U-78517F, ATTENUATES HYPOXIC INJURY IN ISOLATED CARDIAC MYOCYTES, Journal of Molecular and Cellular Cardiology, 26(9), 1994, pp. 1249-1257
Citation: Tm. Wall et al., BRADYKININ RELATED CARDIOPROTECTION IN ISCHEMIC PRECONDITIONING IS MEDIATED BY K(ATP) CHANNELS, Circulation, 90(4), 1994, pp. 475-475
Citation: Tm. Wall et al., BRADYKININ RELATED CARDIOPROTECTION IN ISCHEMIC PRECONDITIONING IS MEDIATED BY K(ATP) CHANNELS, Circulation, 90(4), 1994, pp. 475-475
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE IN RABBITS BY RAMIPRILAT - REVERSAL BY THE BRADYKININ ANTAGONIST HOE-140, Journal of cardiovascular pharmacology, 21(6), 1993, pp. 996-1003
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE BY RAMIPRILAT IS INDEPENDENT OF ANGIOTENSIN-II SYNTHESIS INHIBITION, European journal of pharmacology, 234(2-3), 1993, pp. 229-236